RainDance Technologies and Life Technologies' Applied Biosystems unit have penned a strategic co-marketing agreement, the companies said last week.
Under the agreement, the firms will co-market RainDance's RDT 1000 sequence enrichment solution, which is based on microdroplet PCR, with ABI's SOLiD system.
In addition, the companies will continue to collaborate to use RainDance products in the SOLiD sequencing workflow.
Researchers at the Translational Genomics Research Institute in Phoenix, Ariz., have already used RainDance's enrichment technology in conjunction with SOLiD sequencing to identify somatic mutations in tumor samples, the companies said.
Both technologies "worked smoothly and offered superb coverage and accuracy," said John Carpten, a senior investigator and director of the Integrated Cancer Genomics Division at TGen, in a statement. "We are looking forward to expanding our use of both the RainDance and SOLiD platforms to other large-scale sequencing projects."